Advertisement
Research Article| Volume 7, ISSUE 3, P639-657, July 1991

Toxic Effects of Bronchodilators

  • Jonathon D. Truwit
    Correspondence
    Address reprint requests to: Jonathon D. Truwit, MD, Pulmonary and Critical Care Medicine, University of Virginia Health Sciences Center, Box 225, Charlottesville, VA 22908
    Affiliations
    Assistant Professor of Medicine, Departments of Pulmonary and Critical Care Medicine, and Director, Medical Intensive Care Unit, the University of Virginia, Health Sciences Center, Charlottesville, Virginia
    Search for articles by this author
DOI:https://doi.org/10.1016/S0749-0704(18)30299-9
Toxic Effects of Bronchodilators
Previous ArticleOpioids and Other Analgesics
Next ArticleToxic Effects of Electrolyte and Trace Mineral Administration in the Intensive Care Unit
      This paper is only available as a PDF. To read, Please Download here.
      The critical care clinician commonly encounters patients with acute bronchospasm. Therapy includes a multidrag regimen of sympathomimetics, anticholinergics, methylxanthines, and corticosteroids. The best use of these agents is predicated on knowledge and avoidance of drag toxicities. This article reviews toxic effects of these bronchodilator agents.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ahrens R.C.
        • Smith G.D.
        Albuterol: An adrenergic agent for use in treatment of asthma. Pharmacology, pharmacokinetics, and clinical use.
        Pharmacotherapy. 1984; 4: 105
        • Aitken M.L.
        • Martin T.R.
        Life-threatening complications of theophylline toxicity are not predicted by serum theophylline levels [abstract].
        Am Rev Respir Dis. 1985; 131: 68
        • Albert R.K.
        • Martin T.R.
        • Lewis S.W.
        Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.
        Ann Intern Med. 1980; 92: 753
        • Amirav I.
        • Amitai Y.
        • Avital A.
        • et al.
        Enhancement of theophylline clearance by intravenous albuterol.
        Chest. 1988; 94: 444
        • Bass M.
        Sudden death.
        JAMA. 1970; 212: 2075
        • Bauer R.
        • Banholzer R.
        • Griben C.
        • et al.
        Ipratropium bromide.
        Pharmacology and Biochemical Properties of Drug Substances. 1979; 2: 489
        • Beisel W.R.
        • Rapoport M.I.
        Inter-relations between adrenal corticofunctions and infectious illness.
        N Engl J Med. 1969; 280: 541
        • Berlinger W.G.
        • Specter R.
        • Goldberg M.J.
        • et al.
        Enhancement of theophylline clearance by oral activated charcoal.
        Clin Pharmacol Ther. 1983; 33: 351
        • Bethel R.A.
        • Irvin C.G.
        Anticholinergic, antimuscarinic drugs (atropine sulfate, ipratropium bromide.
        in: Cherniack R.M. Drugs for the Respiratory System. ed 1. Grune & Stratton, Orlando1986: 61
        • Bowton D.L.
        • Alford P.T.
        • McLees B.D.
        • et al.
        The effect of aminophylline on cerebral blood flow in patients with chronic obstructive pulmonary disease.
        Chest. 1987; 91: 874
        • Bowyer S.L.
        • LaMothe M.P.
        • Hollister J.R.
        Steroid myopathy: Incidence and detection in a population with asthma.
        J Allergy Clin Immunol. 1985; 76: 234
        • Brady H.R.
        • Ryan F.
        • Cunningham J.
        • et al.
        Hypophosphatemia complicating bronchodilator therapy for acute severe asthma.
        Arch Intern Med. 1989; 149: 2367
        • Camarata S.J.
        • Weil M.H.
        • Hanashiro P.K.
        • et al.
        Cardiac arrests in the critically ill: I. A study of predisposing causes in 132 patients.
        Circulation. 1971; 44: 688
        • Carpentiere G.
        • Marino S.
        • Castello F.
        Furosemide and theophylline.
        Ann Intern Med. 1985; 103: 957
        • Chang K.C.
        • Lauer B.A.
        • Bell T.D.
        • et al.
        Altered theophylline pharmacokinetics during acute respiratory viral illness.
        Lancet. 1978; 1: 1132
        • Chang S.
        • King T.E.
        Corticosteroids.
        in: Cherniack R.M. Drugs for the Respiratory System. ed 1. Grune & Stratton, Orlando1986: 77
        • Clark T.JH.
        Safety of inhaled corticosteroids.
        Eur J Respir Dis. 1982; 63: 235
        • Clark T.JH.
        Inhaled corticosteroid therapy: A substitute for theophylline as well as prednisolone.
        J Allergy Clin Immunol. 1985; 76: 330
        • Colacone A.
        • Wolkove N.
        • Stern E.
        • et al.
        Continuous nebulization of albuterol (salbutamol) in acute asthma.
        Chest. 1990; 97: 693
        • Collins J.M.
        • McDevitt D.G.
        • Shanks R.G.
        • et al.
        The cardiotoxicity of isoproterenol during hypoxia.
        Br J Pharmacol. 1969; 36: 35
        • Connoly C.K.
        Adverse reaction to ipratropium bromide.
        Br Med J. 1982; 285: 934
        • Conrad K.A.
        • Nyman D.W.
        Effects of metoprolol and propranolol on theophylline elimination.
        Clin Pharmacol Ther. 1980; 28: 463
        • Conradson T.B.
        • Eklundh G.
        • Olofsson B.
        • et al.
        Arrhythmogenicity from combined bronchodilator therapy in patients with obstructive lung disease and concomitant ischemic heart disease.
        Chest. 1987; 91: 5
        • Cooper M.J.
        • Abinader E.G.
        Atropine-induced ventricular fibrillation: Case report and review of the literature.
        Am Heart J. 1979; 97: 225
        • Cordess-Folstein M.
        • Drachman D.
        Psychiatric effects of alternate-day steroid therapy.
        Br J Psychiatry. 1981; 138: 504
        • Crompton G.K.
        Nebulized or intravenous β2-adrenoceptor agonist therapy in acute asthma.
        Eur Respir J. 1990; 3: 125
        • Cugell D.W.
        Clinical pharmacology and toxicology of ipratropium bromide.
        Am J Med. 1986; 81: 18
        • Dollery C.T.
        The toxicity of propellant gases.
        An evaluation of bronchodilator drugs, in Asthma Research Council Symposium. Trust for Education and Research and Therapeutics, London1974: 183
        • Dollery C.T.
        • Williams F.M.
        • Draffan G.H.
        Arterial blood levels of fluorocarbons in asthmatic patients following use of pressurized aerosol.
        Clin Pharmacol Ther. 1974; 15: 59
        • Dulfano M.J.
        • Glass P.
        The bronchodilator effects of terbutaline. Route of administration and patterns of response.
        Ann Allergy. 1976; 37: 357
        • Dunlap N.E.
        • Bailey W.C.
        Corticosteroids in asthma.
        South Med J. 1990; 83: 428
        • Dunwiddie T.V.
        • Hoffer B.J.
        • Fredholm B.B.
        Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine.
        Naunyn Schmiedebergs Arch Pharmacol. 1981; 316: 326
        • Elias J.A.
        • Levenson A.L.
        Hypersensitivity reactions to ethylenediamine in aminophylline.
        Am Rev Respir Dis. 1981; 123: 550
        • Ellis E.F.
        Theophylline toxicity.
        J Allergy Clin Immunol. 1985; 76: 297
        • Engel W.
        • et al.
        Myasthenia gravis.
        Ann Intern Med. 1974; 81: 225
        • Engelhardt A.
        Pharmacology and toxicology of atrovent.
        Scand J Respir Dis. 1979; 103: 110
        • Esau S.A.
        Theophylline enhances fatigue in hamster diaphragm. Am Rev Respir Dis.
        Study in a hypoxic, hypercapnic environment. 1989; 139: A162
        • Fanta C.H.
        • Rossing T.H.
        • McFadden Jr., E.R.
        Glucocorticoids in acute asthma—a critical controlled trial.
        Am J Med. 1983; 74: 845
        • Fernandez E.
        • Cherniack R.M.
        β2-agonists.
        in: Cherniack R.M. Drugs for the Respiratory System. ed 1. Grune & Stratton, Orlando1986: 1
        • Field G.B.
        The effects of posture, oxygen, isoproterenol, and atropine on ventilation-perfusion relationships in the lung in human asthma.
        Clin Sci. 1967; 32: 279
        • Folli H.L.
        • Cupit G.C.
        Ethylenediamine hypersensitivity.
        Drug Intell Clin Pharm. 1978; 12: 482
        • Gardner M.J.
        • Schatz M.
        • Cousins L.
        • et al.
        Longitudinal effects of pregnancy on the pharmacokinetics of theophylline.
        Eur J Clin Pharmacol. 1987; 31: 289
        • Gaudreault P.
        • Wason S.
        • Lovejoy F.H.
        Pediatric theophylline overdose; a summary of 28 cases.
        J Pediatr. 1983; 102: 474
        • Gay P.
        • Taiyoob M.
        • Rodarte J.R.
        • et al.
        The assessment of bronchodilator responsiveness during controlled mechanical ventilation [abstract].
        Am Rev Respir Dis. 1987; 136: 880
        • Gilbert I.A.
        • McFadden E.R.
        Managing the acute asthma attack. Drug Therapy.
        β-agonists and methylxanthines. 1988; 18: 21
        • Ginchansky E.
        • Weinberger M.
        Relationships of theophylline clearance to oral dosage in children with chronic asthma.
        J Pediatr. 1977; 91: 655
        • Glaser G.H.
        Psychotic reactions induced by corticotrophin (ACTH) and cortisone.
        Psychosom Med. 1953; 15: 280
        • Grieco M.H.
        The role of corticosteroid therapy in infection.
        Hosp Pract. 1984; 19: 131
        • Gross N.J.
        • Skorodin M.S.
        Anticholinergic, antimuscaranic bronchodilators. State of the art.
        Am Rev Respir Dis. 1984; 129: 856
        • Haanaes O.C.
        • Bergmann A.
        Tuberculosis emerging in patients treated with corticosteroids.
        Eur J Respir Dis. 1983; 64: 294
        • Habib M.P.
        • Campbell S.C.
        • Shon B.Y.
        • et al.
        A comparison of albuterol and metaproterenol nebulizer solutions.
        Ann Allergy. 1987; 58: 421
        • Halliday A.M.
        • Redfern J.WT.
        An analysis of the frequencies of tremor in healthy subjects.
        J Physiol (Lond. 1956; 134: 600
        • Hardy C.
        • Schofield O.
        • George C.F.
        Allergy to aminophylline.
        Br Med J. 1983; 286: 2051
        • Helliwell M.
        • Berry D.
        Theophylline poisoning in adults.
        Br Med J. 1979; 2: 1114
        • Hemstreet M.P.
        • Miles M.V.
        • Rutland R.O.
        Effective intravenous isoproterenol on theophylline kinetics.
        J Allergy Clin Immunol. 1982; 69: 360
        • Hendeles L.
        • Bighley L.
        • Richardson R.H.
        • et al.
        Frequent toxicity from IV aminophylline infusions in critically ill patients.
        Drug Intell Clin Pharm. 1977; 11: 12
        • Hendeles L.
        • Weinberger M.
        Theophylline, a "state of the art" review.
        Pharmacotherapy. 1983; 3: 2
        • Higgins R.M.
        • Cookson W.OCM.
        • Lane D.J.
        • et al.
        Cardiac arrhythmias caused by nebulized β-agonist therapy.
        Lancet. 1987; 2: 863
        • Higgins R.M.
        • Stradling J.R.
        • Lane D.J.
        Should ipratropium bromide be added to β-agonists in treatment of acute severe asthma?.
        Chest. 1988; 94: 718
        • Ho G.
        • Tierney M.G.
        • Dales R.E.
        Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline.
        Clin Pharmacol Ther. 1988; 44: 35
        • Hoglund P.
        • Nilsson L.G.
        • Paulsen O.
        Interaction between isoniazid and theophylline.
        Eur J Respir Dis. 1987; 70: 110
        • Holden R.
        Probable fatal interaction between ciprofloxacin and theophylline.
        Br Med J. 1988; 297: 1339
        • Hunt S.N.
        • Jusko W.J.
        • Yurchak A.M.
        Effect of smoking on theophylline disposition.
        Clin Pharmacol Ther. 1976; 19: 546
        • IPPB trial group
        Intermittent positive pressure therapy of chronic obstructive pulmonary disease.
        Ann Intern Med. 1983; 99: 612
        • Jackson R.H.
        • Garrido R.
        • Silverman H.I.
        • et al.
        Blood levels following oral administration of theophylline preparations.
        Ann Allergy. 1973; 31: 413
        • Jackson R.H.
        • McHenry J.I.
        • Moreland F.B.
        • et al.
        Clinical evaluation of elixophylline with correlation of pulmonary function studies and theophylline serum levels in acute and chronic asthmatic patients.
        Dis Chest. 1964; 45: 75
        • Jasper A.C.
        • Mohsenifaz Z.
        • Kahan S.
        • et al.
        Cost—benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients.
        Chest. 1987; 91: 614
        • Jonsson S.
        • Kjartansson G.
        • Gislason D.
        • et al.
        Comparison of oral and intravenous routes for treating asthma with methylprednisolone and theophylline.
        Chest. 1988; 94: 723
        • Jusko W.J.
        • Schentag J.J.
        • Clark J.H.
        • et al.
        Enhanced biotransformation of theophylline in marijuana and tobacco smokers.
        Clin Pharmacol Ther. 1978; 24: 405
        • Kappas A.
        • Anderson K.E.
        • Conney A.H.
        • et al.
        Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
        Clin Pharmacol Ther. 1976; 20: 643
        • Khaleeli A.A.
        • Edwards R.HT.
        • Gohilk A.L.
        Corticosteroid myopathy: A clinical and pathological study.
        Clin Endocrinol. 1983; 18: 155
        • Khan M.A.
        Plasma potassium in acute severe asthma before and after treatment.
        British Journal of Clinical Practice. 1989; 43: 363
        • Kongragunta V.R.
        • Druz W.S.
        • Sharp J.T.
        Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease—responses to theophylline.
        Am Rev Respir Dis. 1988; 137: 662
        • Labaan J.P.
        • lung B.
        • Chauvet J.P.
        • et al.
        Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus.
        Chest. 1988; 94: 496
        • Lakshiminarayan S.
        Ipratroprium bromide in chronic bronchitis/emphysema: A review of literature.
        Am J Med. 1986; 81 (suppl 5A): 76
        • Lamont H.
        • van der Straeten M.
        • Pauwels R.
        • et al.
        The combined effect of theophylline and terbutaline in patients with chronic obstructive disease.
        Eur J Respir Dis. 1982; 63: 13
        • Landay R.A.
        • Gonzalez M.A.
        • Taylor J.C.
        Effects of phenobarbital on theophylline disposi tion.
        J Allergy Clin Immunol. 1978; 62: 27
        • Larsson S.
        • Svedmyr N.
        Bronchodilating effect and side effects of β2-adrenoceptor stimulants by different modes by administration (tablets, metered dose aerosol, and a combination thereof.
        Am Rev Respir Dis. 1977; 116: 861
        • Lawford G.
        • Jones B.JM.
        • Millage J.S.
        Comparison of intravenous and nebulized salbutamol in the initial treatment of severe asthma.
        Br Med J. 1978; 1: 84
        • Lawrence I.D.
        • Patterson R.
        Topical respiratory therapy.
        Adv Intern Med. 1990; 35: 27
        • Littenberg B.
        Aminophylline treatment in severe acute asthma—a meta-analysis.
        JAMA. 1988; 259: 1678
        • Littenberg B.
        • Gluck E.H.
        A controlled trial of methylprednisolone in the emergency treatment of acute asthma.
        N Engl J Med. 1986; 314: 150
        • Lockett M.F.
        Dangerous effects of isoproterenol in myocardial failure.
        Lancet. 1965; 2: 104
        • Loren M.L.
        • Chai H.
        • Leung P.
        • et al.
        Corticosteroids in the treatment of acute exacerbations of asthma.
        Ann Allergy. 1980; 45: 67
        • Lunde P.
        Ventricular fibrillation after intravenous atropine for sinus bradycardia.
        Acta Med Scand. 1976; 199: 369
        • Maitre M.
        • Ciesielski L.
        • Lehmann A.
        • et al.
        Protective effect of adenosine and nicotinamide against audiogenic seizure.
        Biochem Pharmacol. 1974; 23: 2807
        • Malani J.
        • Robinson G.
        • Senevirante E.
        Ipratropium bromide induced angle closure glaucoma [letter].
        NZ Med J. 1982; 95: 749
        • Manfredi R.L.
        • Vesell E.S.
        Inhibition of theophylline metabolism by long-term allopurinol administration.
        Clin Pharmacol Ther. 1981; 29: 224
        • Marquise J.F.
        • Carruthers S.G.
        • Spence J.D.
        • et al.
        Phenytoin-theophylline interactions.
        N Engl J Med. 1982; 307: 1189
        • Massey K.L.
        • Gotz V.P.
        Ipratropium bromide.
        Drug Intell Clin Pharm. 1985; 19: 5
        • Massumi R.A.
        • Mason D.T.
        • Amsterdam E.A.
        • et al.
        Ventricular fibrillation and tachycardia after intravenous atropine for treatment of bradycardias.
        N Engl J Med. 1972; 287: 336
        • Matthay R.A.
        • Berger H.J.
        • Davies R.
        • et al.
        Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease.
        Am Heart J. 1982; 104: 1022
        • McWilliams B.
        • Kelly W.
        • Murphy S.
        Management of acute severe asthma.
        Pediatr Ann. 1989; 18: 774
        • Moler F.W.
        • Hurwitz M.E.
        • Custer J.R.
        Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline.
        J Allery Clin Immunol. 1988; 81: 1101
        • Molkenboer J.
        • Lardenoye J.
        The effect of Atrovent in micturition function, double-blind cross-over study.
        Scand J Respir Dis. 1979; 103: 154
        • Monks T.J.
        • Caldwell J.
        • Smith R.L.
        Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
        Clin Pharmacol Ther. 1979; 26: 513
        • Morgan M.DL.
        • Singh B.V.
        • Frame M.H.
        • et al.
        Terbutaline aerosol given through pear spacers in acute severe asthma.
        Br Med J. 1982; 285: 849
        • Morley J.
        • Sanjar S.
        • Newts C.
        Viewpoint: Untoward effects of β-adrenoceptor agonists in asthma.
        Eur Respir J. 1990; 3: 228
        • Murciano D.
        • Aubier M.
        • Lecocquic Y.
        • et al.
        Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease.
        N Engl J Med. 1984; 311: 349
        • Murciano D.
        • Auclair M.H.
        • Pariente R.
        • et al.
        A randomized controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
        N Engl J Med. 1989; 320: 1521
        • Nelson H.S.
        • Raine D.
        • Donner H.C.
        • et al.
        Subsensitivity to bronchodilator action of albuterol produced by chronic administration.
        Am Rev Respir Dis. 1977; 116: 871
        • Newhouse M.T.
        • Tolovich M.
        Aerosol therapy of reversible airflow obstruction: Concepts and clinical applications.
        Chest. 1987; 91: 58s
        • Pakes G.E.
        Anti-cholinergic drugs.
        in: Buckle D.R. Smith H. Development of anti-asthma drugs. Butterworths, London1984
        • Pakes G.E.
        • Brogden R.
        • Heel R.
        • et al.
        Ipratropium bromide: A review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.
        Drugs. 1980; 20: 237
        • Pancordo S.
        • Fifield G.
        • Davis S.
        Subcutaneous epinephrine versus nebulized terbutaline in the emergency treatment of asthma.
        Clin Pharmacol. 1983; 2: 45
        • Park G.D.
        • Specter R.
        • Roberts R.J.
        • et al.
        Use of hemoperfusion for treatment of theophylline intoxication.
        Am J Med. 1983; 74: 961
        • Patrick D.M.
        • Dales R.E.
        • Stark R.M.
        • et al.
        Severe exacerbations of COPD and asthma; incremental benefit of adding ipratropium to usual therapy.
        Chest. 1990; 98: 295
        • Pavia D.
        • Bateman J.
        • Sheahan N.
        • et al.
        Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction.
        Thorax. 1979; 34: 501
        • Pedersen S.
        Delay in the absorption rate of theophylline from a sustained-released theophylline preparation caused by food.
        Br J Clin Pharmacol. 1981; 12: 904
        • Petrozzi J.W.
        • Shore R.N.
        Generalized exfoliative dermatitis from ethylenediamine.
        Arch Dermatol. 1976; 112: 525
        • Piafsky K.M.
        • Sitar D.S.
        • Rangno R.E.
        • et al.
        Theophylline kinetics in acute pulmonary edema.
        Clin Pharmacol Ther. 1977; 21: 310
        • Piafsky K.M.
        • Sitar D.S.
        • Rangno R.E.
        • et al.
        Theophylline disposition in patients with hepatic cirrhosis.
        N Engl J Med. 1977; 296: 1495
        • Pierson D.J.
        • Hudson L.D.
        • Stark K.
        • et al.
        Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.
        Chest. 1980; 77: 176
        • Plummer A.L.
        The development of drug tolerance to p2-adrenergic agents.
        Chest. 1978; 73: 949
        • Portnoy J.
        • Aggarwal J.
        Continuous terbutaline nebulization for treatment of severe exacerbations of asthma in children.
        Ann Allergy. 1988; 60: 368
        • Prince R.A.
        • Wing D.S.
        • Weinberger M.M.
        • et al.
        Effect of erythromycin on theophylline kinetics.
        J Allergy Clin Immunol. 1981; 68: 427
        • Provost T.T.
        • Jillson O.F.
        Ethylenediamine contact dermatitis.
        Arch Dermatol. 1967; 96: 231
        • Ratto D.
        • Alfaro C.
        • Sipsey J.
        • et al.
        Are intravenous corticosteroids required in status asthmaticus?.
        JAMA. 1988; 260: 527
        • Rebuck A.S.
        • Chapman K.R.
        • Braude A.C.
        Anticholinergic therapy of asthma.
        Chest. 1982; 82: 55s
        • Reed C.E.
        β-agonists: Adrenergic bronchodilators; pharmacology and toxicology.
        J Allergy Clin Immunol. 1985; 76: 335
        • Reisman R.E.
        Asthma induced by adrenergic aerosol.
        J Allergy. 1970; 46: 162
        • Reitberg D.P.
        • Bernhard H.
        • Schentag J.J.
        Alteration of theophylline clearance and half life by cimetidine in normal volunteers.
        Ann Intern Med. 1981; 95: 582
        • Renton K.W.
        • Gray J.D.
        • Hall R.I.
        Decreased elimination of theophylline after influenza vaccination.
        Can Med Assoc J. 1980; 123: 288
        • Reyes De Rocha S.
        • Brown M.A.
        Asthma in children: Emergency management.
        Ann Emerg Med. 1987; 16: 79
        • Rice K.L.
        • Leatherman J.W.
        • Duane P.G.
        • et al.
        Aminophylline for acute exacerbations of chronic obstructive pulmonary disease—a controlled trial.
        Ann Intern Med. 1987; 107: 305
        • Richman S.
        Adverse effects of atropine during myocardial infarction. Enhancement of ischemia following intravenously administered atropine.
        JAMA. 1974; 228: 1414
        • Rominger K.
        Chemistry and pharmacokinetics of ipatoprium bromide.
        Scan J Respir Dis. 1979; 103: 116
        • Rosenkrantz T.S.
        • Oh W.
        Aminophylline reduces cerebral blood flow velocity in low birth weight infants.
        Am J Dis Child. 1984; 138: 489
        • Rossing T.H.
        • Fanta C.H.
        • Goldstein D.H.
        • et al.
        Emergency therapy of asthma: Comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline.
        Am Rev Respir Dis. 1980; 122: 365
        • Ruffin R.
        • Wolff P.
        • Dolovich M.
        • et al.
        Aerosol therapy with SCH 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects.
        Chest. 1978; 73: 501
        • Sackner M.A.
        • Daugherty R.
        • Watson H.
        • et al.
        Hemodynamic effects of epinephrine and terbutaline in normal man.
        Chest. 1975; 68: 616
        • Sackner M.A.
        • Friedman M.
        • Silva G.
        • et al.
        The pulmonary hemodynamic effects of aerosols of isoproterenol and ipratropium in normal subjects and patients with reversible airway obstruction.
        Am Rev Respir Dis. 1977; 116: 1013
        • Saven A.
        • Lippmann M.L.
        Aminophylline allergy.
        Am J Med. 1987; 82: 1092
        • Schlueter D.P.
        Ipratroprium bromide in asthma: A review of literature.
        Am J Med. 1986; 81 (suppl 5A): 55
        • Sessler C.N.
        Theophylline toxicity: Clinical features of 116 consecutive cases.
        Am J Med. 1990; 88: 567
        • Sessler C.N.
        • Glauser F.L.
        • Cooper K.R.
        Treatment of theophylline toxicity with oral activated charcoal.
        Chest. 1985; 87: 325
        • Siegel D.
        • Sheppard D.
        • Gleb A.
        • et al.
        Aminophylline increases the toxicity but not the efficacy of an inhaled β-adrenergic agonist in the treatment of acute exacerbations of asthma.
        Am Rev Respir Dis. 1985; 132: 283
        • Siegel S.C.
        Corticosteroid agents: Overview of corticosteroid therapy.
        J Allergy Clin Immunol. 1985; 76: 312
        • Simpson D.L.
        • Goodman M.
        • Spector S.L.
        • et al.
        Long-term follow-up and bronchial reactivity testing in survivors of adult respiratory distress syndrome.
        Am Rev Respir Dis. 1978; 117: 449
        • Sirmans S.M.
        • Pieper J.A.
        • Lalonde R.L.
        • et al.
        Effect of calcium channel blockers on theophylline deposition.
        Clin Pharmacol Ther. 1988; 44: 29
        • Speizer F.E.
        • Doll R.
        • Heaf P.
        Observations on recent increase in mortality from asthma.
        Br Med J. 1968; 1: 335
        • Speizer F.E.
        • Doll R.
        • Heaf P.
        • et al.
        Investigation into use of drugs preceding death from asthma.
        Br Med J. 1968; 1: 339
        • Stibolt T.B.
        • Youtsey D.J.
        • Buist A.S.
        Cardiac toxicity of theophylline, albuterol, and the combination in severe COPD.
        Am Rev Respir Dis. 1989; 139: A14
        • Stiles G.L.
        • Taylor S.
        • Lefkowitz R.J.
        Human cardiac ^-adrenergic receptors: Heterogeneity delineated by direct ligand binding.
        Life Sci. 1983; 33: 467
        • Suzuki A.
        • Nishimura M.
        • Akiyama Y.
        • et al.
        Aminophylline reduces the brain tissue PO2 in COPD patients.
        Am Rev Respir Dis. 1989; 139: A11
        • Szefler S.J.
        Practical considerations in the safe and effective use of theophylline.
        Pediatr Clin North Am. 1983; 30: 943
        • Szefler S.J.
        Theophylline and other methylxanthine derivatives.
        in: Cherniack R.M. Drugs for the respiratory system. ed 1. Grune & Stratton, Orlando1986: 21
        • Thiessen B.
        • Pedersen O.F.
        A double-blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics, and bronchitics after salbutemol and ipratropium.
        Scand J Respir Dis. 1979; 103: 170
        • Thomas D.
        • Gill B.
        Salbutamol-induced diabetic ketoacidosis.
        Br Med J. 1977; 2: 438
        • Thompson P.J.
        • Skypala I.
        • Dawson S.
        • et al.
        The effect of diet upon serum concentrations of theophylline.
        Br J Clin Pharmacol. 1983; 16: 267
        • Thringer G.
        • Svedmyr N.
        Comparison of infused and inhaled terbutaline in patients with asthma.
        Scand J Respir Dis. 1976; 57: 17
        • Thumm H.
        Ophthalmic effects of high doses of SCH 1000 MDI in healthy volunteers and patients with glaucoma.
        Postgrad Med J. 1975; 51 (suppl 7): 132
        • Tornatore K.M.
        • Kanarkowski E.
        • McCarthy T.L.
        • et al.
        Effect of chronic oral contraceptive steroids on theophylline disposition.
        Eur J Clin Pharmacol. 1982; 23: 129
        • Truwit J.D.
        • Marini J.J.
        Evaluation of thoracic mechanics in the ventilated patient. Part II: Applied mechanics.
        J Crit Care. 1988; 3: 199
        • Vicuna N.
        • McNay J.L.
        • Ludden T.M.
        • et al.
        Impaired theophylline clearance in patients with cor pulmonale.
        Br J Clin Pharmacol. 1979; 7: 33
        • Voss K.R.
        • Willsie-Ediger S.K.
        • Pysczzynski D.R.
        • et al.
        Description of a delivery method for continuously aerosolized albuterol in status asthmaticus.
        J Asthma. 1990; 27: 37
        • Ward M.J.
        • Fentem P.H.
        • Roderick-Smith W.H.
        • et al.
        Ipratroprium bromide in acute asthma.
        Br Med J. 1981; 282: 596
        • Webb D.R.
        Beclomethasone in steroid-dependent asthma. Effective therapy and recovery of hypothalamic-pituitary-adrenal function.
        JAMA. 1977; 238: 1508
        • Weiner N.
        Atropine, scopolamine, and related antimuscarinic drugs.
        in: Gilman A.G. Goodman L.S. Gilman A. The Pharmacologic Basis of Therapeutics. ed 6. Macmillan, New York1980: 120-159A
        • Wechsler R.L.
        • Kleiss L.M.
        • Ketz S.S.
        The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man.
        J Clin Invest. 1950; 29: 28
        • Williams S.J.
        • Winter S.J.
        • Clark T.JH.
        Comparison of inhaled and intravenous terbutaline in acute severe asthma.
        Thorax. 1981; 36: 629
        • Wright P.E.
        • Marini J.J.
        • Gordon R.B.
        In vitro versus in vivo comparison of endotracheal tube airflow resistance.
        Am Rev Respir Dis. 1989; 140: 10
        • Ziment I.
        Cardiovascular side effects in patients requiring bronchodilator therapy.
        Cardiovasc Rev Rep. 1984; 5: 443
        • Ziment I.
        • Au J.P.
        Making the best use of aminophylline in the ICU.
        Journal of Critical Illness. 1986; 1: 21
        • Zwillich C.W.
        • Sutton F.D.
        • Neff T.A.
        • et al.
        Theophylline-induced seizures in adults: Correlation with serum concentrations.
        Ann Intern Med. 1975; 81: 784

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0749-0704(18)30299-9

      Copyright

      © 1991 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX